Showing 20 of 48 recruiting trials for “immunoglobulin-a-nephropathy”
PS-002 for the Treatment of IgA Nephropathy in Adults
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
RecruitingNCT07156149 ↗
Fabhalta Capsules Specified Drug-use Survey
A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy
🏥 Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.📍 1 site📅 Started Sep 2025View details ↗
Nefecon and Ambrisentan in IgA Nephropathy
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Study of BHV-1400 in IgA Nephropathy
A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Atacicept in Multiple Glomerular Diseases
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients With C3-Glomerulopathy
Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)
RecruitingNCT06926244 ↗
RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
Study of Ravulizumab in Pediatric Participants With Primary IgAN
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
Monthly Dosing of Atacicept in IgAN
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
Page 1 of 3Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →